A new, greener process with lower manufacturing costs - MPTxpress

MicroProtein Technologies is the first company to produce recombinant biologics on an industrial scale without employing the conventional fermentation process.
Our facilities and CMO services are now cGMP certified.

Learn More
 

Latest News June 2018:  MicroProtein Receives ISO 9001:2015 GMP Certification April 2018:  J. Schroeder Joins MicroProtein Technologies as Director of Quality April 2018:  S.R. Rangineni, M.D., has Joined MicroProtein as Vice President of Business Development and Strategy April 2016:  MicroProtein Technologies now offers affinity Protein L Jan. 2015:  MicroProtein Technologies moves into new facilities and offers MPTxpress CMO services Sept. 2014:  Article about MPTxpress published in BioProcess International Dec. 2012:  MicroProtein Technologies now offers affinity Proteins - Protein A, Protein G and Protein AG Aug. 2012:  Frost & Sullivan recognizes MicroProtein for its Innovative Production Technology MPT’s clients/customers Asahi Kasei
AnaptysBio Inc
Beckman Coulter
BioToolomics
Entera Health
GT Biopharma
Imgenex
Kane Biotech
Kerry
LakePharma Inc
Luna Nanotech
Life Technologies Corporation
Medella Health
Median Biotech
Median Diagnostics
MedMira
Natrix Separations Inc/MilliporeSigma
New EnglandBioLabs
National Institute of Health
Ocean Nanotech
Puridify/GE Healthcare
Rush University Medical Center
ScienTech Corp
SciGenome Labs
Stanford University
StemCell Technologies
Takara Bio USA Inc
University of Arkansas Medical Center
Vircell Microbiologists

Few samples of CRO and CMO projects performed at MicroProtein Technologies Inc.


G1: SDS-PAGE Analysis of Biologic Drug Substance SB1 (sdAbs/Nanobodies).
Lane 1, M.W marker; Lane 2, SB1 5ug reducing condition; Lane 3, SB1 5ug non-reducing condition.
GMP grade Biologic Drug Substance SB1 manufactured at MicroProtein Technologies.

G2: SDS-PAGE Analysis of Biologic Drug Substance KB1 (Enzyme drug).
Lane 1, MW markers; Lane 2, 0.5ug; Lane 3, 1ug; Lane 4, 2ug reducing condition.
GMP grade Biologic Drug Substance KB1 manufactured at MicroProtein Technologies.

G3: 2ug of GMP-grade recombinant human FGF basic resolved by SDS-PAGE reducing conditions, showing a single band at 17 kDa.

G4: 2ug of recombinant human IL-2 resolved by SDS-PAGE reducing condition, showing a single band at 15.5 kDa.

G5: 2ug of recombinant Protein G resolved by SDS-PAGE reducing condition, showing a single band of 22.5 kDa.

G6: 2ug of recombinant Protein A resolved by SDS-PAGE reducing condition, showing a single band of 35 kDa.